Found: 1
Select item for more details and to access through your institution.
Endostatin 33 Peptide Is a Deintegrin α6β1 Agent That Exerts Antitumor Activity by Inhibiting the PI3K-Akt Signaling Pathway in Prostate Cancer.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 5, p. 1861, doi. 10.3390/jcm12051861
- By:
- Publication type:
- Article